230 related articles for article (PubMed ID: 38294332)
1. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
2. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada.
Alshannaq H; Isitt JJ; Pollock RF; Norman GJ; Cogswell G; Lynch PM; Roze S
J Comp Eff Res; 2023 Oct; 12(10):e230075. PubMed ID: 37668608
[No Abstract] [Full Text] [Related]
3. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
Alshannaq H; Cogswell G; Pollock RF; Ahmed W; Norman GJ; Lynch PM; Roze S
Diabetes Obes Metab; 2023 Sep; 25(9):2704-2713. PubMed ID: 37334522
[TBL] [Abstract][Full Text] [Related]
4. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
5. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
Isitt JJ; Roze S; Tilden D; Arora N; Palmer AJ; Jones T; Rentoul D; Lynch P
Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK.
Isitt JJ; Roze S; Sharland H; Cogswell G; Alshannaq H; Norman GJ; Lynch PM
Diabetes Ther; 2022 Dec; 13(11-12):1875-1890. PubMed ID: 36258158
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
Chaugule S; Graham C
J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
[TBL] [Abstract][Full Text] [Related]
8. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P; Klinkenbijl B; Zammit G; Benhamou PY
Diabetes Ther; 2021 Jan; 12(1):235-246. PubMed ID: 33165838
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P
Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
Roze S; Smith-Palmer J; Valentine W; Payet V; de Portu S; Papo N; Cucherat M; Hanaire H
Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
13. Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
Elliott RA; Rogers G; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Sutton CJ; Taxiarchi VP; Burns M; Thabit H; Wilmot EG; Leelarathna L;
Diabet Med; 2024 Mar; 41(3):e15232. PubMed ID: 37750427
[TBL] [Abstract][Full Text] [Related]
14. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW
Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346
[TBL] [Abstract][Full Text] [Related]
16. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
19. The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes.
Fonda SJ; Graham C; Munakata J; Powers JM; Price D; Vigersky RA
J Diabetes Sci Technol; 2016 Jul; 10(4):898-904. PubMed ID: 26843480
[TBL] [Abstract][Full Text] [Related]
20. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Tunis SL; Willis WD; Foos V
Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
